Overview and Usage
Brand name- Gefitero
Generics- Gefitinib
Manufacturer- Hetro healthcare ltd.
Dosage form- Tablet
Route of Administration- oral
Strength- 250mg
Composition- Gefitinib
Packaging- Strip
Indication- non-small cell lung cancer (NSCLC).
Storage- Store at room temperature (10-30°C)
Class of drug- Anti-Neoplastics
Mechanism Of Action
It works by blocking the action of abnormal protein that signals cancer cells to multiply. This in turn helps to slow or inhibit the spread of cancer cells
Side effects-
The most common side effects of gefitero include nausea, rash, vomiting and weight loss. It may cause severe diarrhea, drink plenty of fluids or consult the doctor if it happens. It makes the patient sensitive towards sunlight, hence wear protective clothing or use sunscreen while going out.
Pharmacodynamics
It is the study of drug effects and what the medicine does to the body
It inhibits the intracellular phosphorylation of tyrosine kinase associated with epidermal growth factor (EGFR).
Pharmacokinetics
Study of what body does to the medicine.Gefitinib is absorbed slowly after oral administration as it has bioavailability of 60%. Elimination is through metabolism (primarily CYP 3A4) and excretion in feces.
Bioavailability Rate
Gefitero is slowly absorbed, with peak plasma levels in 3-7 hours after dosing and mean oral bioavailability of 60%
Shelf Life
Shelf life is the time period over which the concentration of the active medicinal ingredient in the formulation lowers by 10 percent from its value at time of manufacture.
Its shelf life is 26 months


